ArticleFrontiers in immunology2022

Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.

Xianggui Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.